N Azimi


Affiliation: National Institutes of Health
Country: USA


  1. request reprint
    Azimi N, Jacobson S, Leist T, Waldmann T. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol. 1999;163:4064-72 pubmed
    ..These data suggest the existence of two autocrine loops involving IL-15/IL-15R and IL-2/IL-2R, both contributing to the spontaneous proliferation of HAM/TSP PBMC. ..
  2. request reprint
    Azimi N, Mariner J, Jacobson S, Waldmann T. How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis?. AIDS Res Hum Retroviruses. 2000;16:1717-22 pubmed
    ..On the basis of these studies, we propose a model in which HTLV-1 infection of T cells results in the production of both IL-2 and IL-15 cytokines, growth factors that support the proliferation of T cells. ..
  3. Azimi N, Nagai M, Jacobson S, Waldmann T. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci U S A. 2001;98:14559-64 pubmed
    ..This decrease was caused by both inhibition of proliferation and induction of apoptosis in these cells. The data indicate that IL-15 plays a major role in the maintenance of viral-specific CD8 cells in HAM/TSP. ..